Les om resultatene fra Kantar helsepolitiske barometer 2022.
It is a collaboration to tighten the ties between cancer research and information technology.
Marine Jeanmougin is the new EU advisor in Oslo Cancer Cluster. She defines herself as truly European.
Rebekka Rolfsnes is doing her PhD with the start-up AdjuTec Pharma AS and the Department of Pharmacy at the University of Oslo (UiO). Together, they will look for solutions to antibiotic resistance.
The Life Science Cluster and Oslo Cancer Cluster are collaborating on the competence broker-service for Oslo-based companies.
Tailored counseling, funding assistance, and innovation hangouts are part of the innovation package offered by the new Life Science Growth House at the University of Oslo.